Human placental mesenchymal stromal cell‐derived small extracellular vesicles as a treatment for severe COVID‐19: A double‐blind randomized controlled clinical trial

Human placental mesenchymal stromal cell‐derived small extracellular vesicles as a treatment for severe COVID‐19: A double‐blind randomized controlled clinical trial

Abstract The current study aimed to investigate the effects of human placental mesenchymal stromal cell‐derived small extracellular vesicles (hPMSC‐sEVs) as a treatment for COVID‐19. This double‐blind, randomized, controlled clinical trial was conducted on two groups of patients with COVID‐19‐associ...

Full description

Bibliographic Details
Main Authors: Mohammad Hossein Zamanian, Amir Hossein Norooznezhad, Zohreh Hosseinkhani, Daryoush Hassaninia, Feizollah Mansouri, Siavash Vaziri, Mehrdad Payandeh, Fatemeh Heydarpour, Sara Kiani, Maria Shirvani, Mojgan Rajati, Mitra Bakhtiari, Farzaneh Esmaili, Reza Yarani, Kamran Mansouri
Format: Article
Language:English
Published: Wiley 2024-07-01
Series:Journal of Extracellular Vesicles
Subjects:
COVID‐19
exosomes
extracellular vesicles
mesenchymal stromal cell
Online Access:https://doi.org/10.1002/jev2.12492

Internet

https://doi.org/10.1002/jev2.12492

Similar Items